CompanyUnited StatesUpdated Mar 23, 2026
Puma Venture Capital

Puma Venture Capital

Puma Venture Capital: Investor • focus on Venture Capital • active in North America, United States • offices in United States.

Never miss breaking news

Get instant notifications when new news matching "Puma Venture Capital" are published.

Company Profile

Puma Venture Capital is a venture capital firm dedicated to investing in the robotics and artificial intelligence (AI) ecosystem within the healthcare sector. The firm focuses on technologies that transform medical procedures, aiming to improve patient outcomes, enhance labor productivity, and reduce costs across the healthcare system. Their investment scope includes intelligent platforms, embodied AI agents, next-generation instruments, and foundational robotic systems that enable medical procedures in various settings, from hospitals to clinics. They also target digital ecosystems, remote/connected care platforms, cybersecurity, and network-enabling technologies that power the procedural ecosystem, as well as advanced visualization, navigation, sensing, and intra-procedure diagnostics.

The firm was co-founded in 2023 by Amit Hazan and Dr. Vipul Patel. Their vision was to unite experienced medtech investment professionals with surgeon venture partners who are recognized as key opinion leaders in their respective specialties. This unique combination allows Puma Venture Capital to leverage deep clinical insights alongside rigorous investment expertise to identify and support promising innovations in medical technology.

Puma Venture Capital has made several notable investments in companies at various stages of development. Their portfolio includes firms such as Sovato, EndoQuest Robotics, Mendaera, Medcrypt, Capstan Medical, and Navigantis. These investments span industries like healthcare technology systems and surgical devices, reflecting the firm's commitment to advancing digital and robotic surgery solutions. The firm typically invests in early-stage ventures, including Pre-Seed, Seed, Series A, Series B, and Series C rounds, with an average investment range of $25K to $20M.

The team at Puma Venture Capital brings a diverse and complementary set of skills. Co-founder Amit Hazan contributes over 25 years of medical technology research and investing experience, including a tenure as a Managing Director at Goldman Sachs with deep expertise in medical robotics. Dr. Fred Moll, a pioneering entrepreneur in surgical robotics and co-founder of Intuitive Surgical, provides invaluable clinical and operational perspectives. Scott Zinober, a former Senior Portfolio Manager at Viking Global Investors, adds significant investment discipline from his two decades as a top healthcare investor on Wall Street. Furthermore, the firm is powered by a network of more than 20 surgeon venture partners, led by co-founder Dr. Vipul Patel, who offer collective wisdom, extensive relationships, and an entrepreneurial spirit to both the investment process and portfolio companies.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.